Skip to main content
Clinical Trials/CTRI/2023/09/057989
CTRI/2023/09/057989
Not yet recruiting
未知

EFFICACY OF INTRATHECAL NALBUPHINE AS AN ADJUVANT TO LEVOBUPIVACAINE HEAVY 0.5 % FOR EVALUATING THE DURATION OF ANALGESIA IN PATIENTS UNDERGOING URETEROSCOPIC SURGERIES - A PROSPECTIVERANDOMISED CLINICAL STUDY - NA

Rajarajeswari medical college and hospital0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: N99- Intraoperative and postproceduralcomplications and disorders of genitourinary system, not elsewhere classified
Sponsor
Rajarajeswari medical college and hospital
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\. ASA I and II patients of either sex.
  • 2\.Patients aged between 20 to 50 years
  • 3\. Patients undergoing elective ureteroscopic surgeries.

Exclusion Criteria

  • 1\.Patients with known hypersensitivity to local anaesthetic drugs.
  • 2\.Pregnant and lactating women.
  • 3\.Patients refusal
  • 4\.Local site infection and peripheral vascular disease.
  • 5\.Diagnosed to have neurological disease.
  • 6\.Patients with severe cardiovascular, respiratory, hepatic and renal disease.
  • 7\.Patients with coagulation abnormalities.
  • 8\.Patients with previous spine surgeries, and spine abnormalities.

Outcomes

Primary Outcomes

Not specified

Similar Trials